Department of Anesthesiology, King Fahd Hospital, University of Dammam, Al Khobar, Saudi Arabia.
Department of Anesthesiology, King Fahd Hospital, University of Dammam, Al Khobar, Saudi Arabia -
Minerva Anestesiol. 2016 Dec;82(12):1278-1287. Epub 2016 Apr 22.
We hypothesized that the use of the channeled King Vision™ and Airtraq® would shorten the time for tracheal intubation compared with the Macintosh or GlideScope® laryngoscopes in patients with normal airways.
Eighty-six patients were randomly assigned to intubate the trachea using either the Macintosh (N.=22), Glidescope® (N.=21), Airtraq® (N.=21), or King Vision™ (N.=22) laryngoscope. The primary outcome was the time to tracheal intubation. Secondary outcomes included the laryngoscopic view, numbers of laryngoscopy attempts, first-pass success rate, optimization maneuvers, ease of intubation, and postoperative sore throat.
Compared with the Macintosh and GlideScope®, the use of the channeled videolaryngoscopes had significantly longer times to tracheal intubation (mean times: Airtraq® 44 s [95% CI: 39.6 to 46.7]; King Vision™ 34.5 s [95% CI: 33.1 to 40.2]; Macintosh 20 s [95% CI: 19.7 to 26.7]; GlideScope® 27.9 s [95% CI: 25.1 to 30.7], P<0.002) and caused less mucosal trauma (P=0.006). The King Vision™ is slightly faster than the Airtraq® (P=0.035). Compared with the Macintosh and the Airtraq®, the GlideScope® was easier to use (P<0.001). The 4 groups had comparable glottis views, number of laryngoscopy and optimising manoeuvres and first attempt success rate. The Airtraq® and King Vision™ had a lower incidence of sore throat than with the Macintosh or GlideScope® (P=0.001). No patient had failed intubation.
The King Vision™ and Airtraq® require longer intubation times, as primary outcome, and cause less sore throat than the Macintosh and GlideScope® when used by anesthesiologists with limited experience in patients with normal airways. Our conclusion is difficult to extrapolate to the expert anesthesiologists who are using videolaryngoscopes on a regular basis.
我们假设在气道正常的患者中,与 Macintosh 或 GlideScope®喉镜相比,使用 King Vision™ 和 Airtraq®气道可视喉镜将缩短气管插管时间。
86 名患者被随机分为使用 Macintosh(N=22)、GlideScope®(N=21)、Airtraq®(N=21)或 King Vision™(N=22)喉镜进行气管插管。主要结局是气管插管时间。次要结局包括喉镜视野、喉镜尝试次数、首次插管成功率、优化操作、插管难易程度和术后咽痛。
与 Macintosh 和 GlideScope®相比,使用通道式可视喉镜的气管插管时间明显延长(平均时间:Airtraq®44 秒[95%置信区间:39.6 至 46.7];King Vision™34.5 秒[95%置信区间:33.1 至 40.2];Macintosh 20 秒[95%置信区间:19.7 至 26.7];GlideScope®27.9 秒[95%置信区间:25.1 至 30.7],P<0.002),且黏膜损伤较小(P=0.006)。King Vision™比 Airtraq®略快(P=0.035)。与 Macintosh 和 Airtraq®相比,GlideScope®更容易使用(P<0.001)。4 组的声门视图、喉镜次数和优化操作以及首次尝试成功率相当。Airtraq®和 King Vision™的咽痛发生率低于 Macintosh 或 GlideScope®(P=0.001)。无患者插管失败。
在气道正常的患者中,与经验有限的麻醉医生使用 Macintosh 或 GlideScope®相比,King Vision™和 Airtraq®作为主要结局需要更长的插管时间,但引起的咽痛较少。我们的结论很难外推到经常使用可视喉镜的专家麻醉师。